Clonz Biotech Pvt Ltd
Block No 9, Building-9000, Plot No.7, Survey No 542,
Synergy Square 2, MN park, Genome Valley, Shameerpet
Hyderabad, Telangana 500078
India
ph: +91-40-69006789
info
Narasimha Rao Nedunuri
The Managing Director of Clonz, Narasimha is one of the key founding members of the company.
His passion and vision combined with his academic and industrial experience in the world of Proteins (Proteomics) is the driving force of the company towards developing affordable bio therapeutics.
Narasimha’s Research experience in Cancer Biology at CCMB (Centre for Cellular and Molecular Biology) helped him to contribute through his work at a USA based MNC as Product Manager for its Indian subsidiary and also as a Group Leader – Proteomics & Genomics for a reputed CRO, prior to the birth of Clonz.
His wide exposure to countries like Malaysia, Korea, Thailand, China, France, Germany, Switzerland, and USA on various business assignments is also helping in positioning the company.
Contact him at narasimha.nedunuri@clonzbio.com
Muralidhar Reddy Mamilla
The Chief Operating Officer (COO) of Clonz, Muralidhar is one of the key founding members of Clonz.
His past expertise in development of Biosimilar Monoclonal antibodies is one of the core strengths of the company and he is playing an instrumental role in co-ordinating the various product development activities of Clonz.
Muralidhar’s experience along with the team of early scientists at a reputed pharmaceutical company during the development of the World’s first Therapeutic Biosimilar Monoclonal antibody, is a major strength.
His expertise also contributed in other biotech companies to gain the momentum in development of biosimilars. His innovative thinking and speed filled with commercial elements is a boon to the company.
Contact Murali at muralidhar.mamilla@clonzbio.com
Dr. Sreenivasu Karra
The Head-R&D of Clonz, Dr.Karra is one of the key founding members of Clonz.
His past experience over 16 years of industrial experience in the field of Molecular Biology specifically Cloning and Expression of recombinant therapeutics is an asset of the company.
His extensive research work at different institutions includes his four years of Postdoctoral research experience at Univ. of Maryland Cancer Center, USA, & the Cancer Institute of New Jersey, USA. He had 9 publications in international journals and two patents as his academic assets. Industrial experience in reputed Biotech / Pharma companies in development of Biosimilars, currently helping the Clonz to build strong pipeline of products.
Contact Dr.Karra at sreenivasu.karra@clonzbio.com
Vijay Babu Garlapalli
The Vice-President - Production of Clonz, Vijay is one of the key founding members of Clonz.
His past experience over 10 years of industrial experience in the field of Cell culture and Fermentation specifically upstream of Mammalian Cell lines to produce biotherapeutics is an asset of the company.
Vijay’s experience at a Pharmaceutical giant during the development of various Therapeutic Biosimilar Monoclonal antibodies , is a major strength.
His expertise in Cell culture and Fermentation also contributed to excel in his previous assignments for the development of biosimilars.
Contact Vijay at vijay.garlapalli@clonzbio.com
.
Copyright 2009 Clonz Biotech. All rights reserved.
Clonz Biotech Pvt Ltd
Block No 9, Building-9000, Plot No.7, Survey No 542,
Synergy Square 2, MN park, Genome Valley, Shameerpet
Hyderabad, Telangana 500078
India
ph: +91-40-69006789
info